USCDI Export for the Public

Classification Level Sort descending Data Class Data Class Description Data Element Data Element Description Applicable Standards Submitter Name Submitter Organization Submission Date
Level 2 Procedures

Activity performed for or on a patient as part of the provision of care.

Procedure Status

The status of the procedure (e.g., planned, completed).

Procedure Code (same as current USCDIv1): Health Care Financing Administration Common Procedure Coding System (HCPCS), as maintained and distributed by HHS. http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/index.html Current Procedural Terminology, Fourth Edition (CPT-4), as maintained and distributed by the American Medical Association, for physician services and other health care services. http://www.ama-assn.org/ama/pub/physician-resources/solutions-managing-your-practice/coding-billing-insurance/cpt.page SNOMED International, Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT®) U.S. Edition, September 2019 Release. http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html Optional: International Classification of Diseases ICD-10-PCS 2020. http://www.cms.gov/Medicare/Coding/ICD10/index.html Technology which records dental procedures: Code on Dental Procedures and Nomenclature (CDT), maintained and distributed by the American Dental Association, for dental services. http://www.ada.org/en/publications/cdt Procedure Date: HL7 FHIR Datatypes (dateTime|Period|string|Age|Range) http://hl7.org/fhir/datatypes.html#dateTime http://hl7.org/fhir/datatypes.html#Period http://hl7.org/fhir/datatypes.html#string http://hl7.org/fhir/datatypes.html#Age http://hl7.org/fhir/datatypes.html#Range Procedure Status: HL7 FHIR Event Status (preparation, in-progress, not-done, on-hold, stopped, completed, entered-in-error, unknown). http://hl7.org/fhir/R4/valueset-event-status.html

Maria Michaels CDC
Level 2 Health Insurance Information

Data related to an individual’s insurance coverage for health care.

Group Name

Name of the Employer Account.

NUBC, CPT, HCPCS, HIPPS, ICD-9, ICD-10, DRGs, NDC, POS, NCPDP codes, and X12 codes.

Mark Roberts Leavitt Partners
Level 2 Biologically Derived Product

Material substance originating from a biological entity intended to be transplanted or infused into another (possibly the same) biological entity.

Processing Facility

Provides details on the processing location of the product

ISBT-128 Processing Facility Identification Number

Barbee Whitaker Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)
Level 2 Biologically Derived Product

Material substance originating from a biological entity intended to be transplanted or infused into another (possibly the same) biological entity.

Source Identifier

Provides details on collections and pooled products such as donation identifier

ISBT-128 Donation Identification Number

Barbee Whitaker Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)
Level 2 Biologically Derived Product

Material substance originating from a biological entity intended to be transplanted or infused into another (possibly the same) biological entity.

Division

Provides details on aliquots or when a donation event involves more than one collection

ISBT-128 Division Identifier

Barbee Whitaker Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)
Level 2 Patient Demographics/Information

Data used to categorize individuals for identification, records matching, and other purposes.

Patient Identifier Type

Identifies the type of identifier payers and providers assign to patients

NUBC, CPT, HCPCS, HIPPS, ICD-9, ICD-10, DRGs, NDC, POS, NCPDP codes, and X12 codes.

Mark Roberts Leavitt Partners
Level 1 Medications

Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease.

Medication Administration Patient

The person who received the administered medication. While seemingly self-evident as a part of an administration record, the requirement of the patient being linked to the drug administered is critical (assuming Medication Administrations become part of USCDI

In FHIR R4, https://www.hl7.org/fhir/medicationadministration-definitions.html#Medi…

Scott Gordon Food and Drug Administration
Level 1 Exposure/Contact Information Exposure/Contact Source/Target Participant The source or target of the exposure or contact. Could be person, animal, or location. Either the patient's contact with an entity (person, animal, or substance) or presence at a location where exposure to an agent could have occurred or the patient's contact with an entity (person, animal, or substance) or presence at a location where transmission from the patient could have occurred.

HL7 FHIR® Implementation Guide: Electronic Case Reporting (eCR) based on FHIR R4 HL7 CDA® R2 Implementation Guide: Public Health Case Report - the Electronic Initial Case Report (eICR) HL7 FHIR: US Public Health Exposure Contact Information profile (Observation.component) HL7 CDA: Exposure/Contact Information Observation template (observation/participant)

Laura Conn
Level 1 Genomics Variant Type

The data representing the type of genetic variation. Some examples of variant types include DNA, protein, chromosome.

* SNOMED CT
* LOINC
* HUGO Gene Nomenclature Committee (HGNC) notation
* Genetic Variant standards:
---- Catalogue of Somatic Mutations in Cancer (COSMIC)
---- International System for Human Cytogenic Nomenclature (ISCN)
---- Human Genome Variation Society (HGVS) Nomenclature

LINKS:

SNOMED CT
https://www.snomed.org/snomed-ct/case-studies/binding-snomed-ct-and-gen…

LOINC
https://academic.oup.com/jamia/article/22/3/621/773317

HGNC Notation
https://www.genenames.org/

HGVS Nomenclature
https://varnomen.hgvs.org/

COSMIC
https://cancer.sanger.ac.uk/cosmic

ISCN
https://www.coriell.org/0/sections/support/global/iscn_help.aspx?PgId=2…

Steve Bratt CodeX (Common Oncology Data Elements eXtensions), a member-driven HL7 FHIR Accelerator
Level 1 Medications

Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease.

Medication Module

The medication module is concerned with resources and functionality in 3 main domains: (1) the ordering, dispensing, administration of medications and recording statements of medication use, (2) Recording of Immunizations given (or not given), evaluation of given immunizations and recommendations for an individual patient at a point in time, and (3) The creation or querying for medications as part of drug information or drug knowledge. https://www.hl7.org/fhir/medications-module.html

RxNorm and SNOMED CT

Shelly Spiro Pharmacy HIT Collaborative
Level 1 Exposure/Contact Information Exposure/Contact agent The possible agent of concern in the exposure/contact.

HL7 FHIR® Implementation Guide: Electronic Case Reporting (eCR) based on FHIR R4 HL7 CDA® R2 Implementation Guide: Public Health Case Report - the Electronic Initial Case Report (eICR) HL7 FHIR: US Public Health Exposure Contact Information profile (Observation.component) HL7 CDA: Exposure/Contact Information Observation template (observation/participant)

Laura Conn
Level 1 Exposure/Contact Information Exposure/Contact Date The date or period on which the possible exposure/contact occurred.

HL7 FHIR® Implementation Guide: Electronic Case Reporting (eCR) based on FHIR R4 HL7 CDA® R2 Implementation Guide: Public Health Case Report - the Electronic Initial Case Report (eICR) HL7 FHIR: US Public Health Exposure Contact Information profile (Observation.component) HL7 CDA: Exposure/Contact Information Observation template (observation/participant)

Laura Conn
Level 1 Genomics Variant Interpretation

The categorical or clinical assessment of the genetic variant data, where interpretation is necessary to fully understand the significance.

* SNOMED CT
* LOINC
* HUGO Gene Nomenclature Committee (HGNC) notation
* Genetic Variant standards:
---- Catalogue of Somatic Mutations in Cancer (COSMIC)
---- International System for Human Cytogenic Nomenclature (ISCN)
---- Human Genome Variation Society (HGVS) Nomenclature

LINKS:

SNOMED CT
https://www.snomed.org/snomed-ct/case-studies/binding-snomed-ct-and-gen…

LOINC
https://academic.oup.com/jamia/article/22/3/621/773317

HGNC Notation
https://www.genenames.org/

HGVS Nomenclature
https://varnomen.hgvs.org/

COSMIC
https://cancer.sanger.ac.uk/cosmic

ISCN
https://www.coriell.org/0/sections/support/global/iscn_help.aspx?PgId=2…

Steve Bratt CodeX (Common Oncology Data Elements eXtensions), a member-driven HL7 FHIR Accelerator
Level 1 Patient Demographics/Information

Data used to categorize individuals for identification, records matching, and other purposes.

Patient Birth Place

The city, state, county and country or location in which the patient was born.

FHIR patient extension: birthplace FHIR patient address.period

Adam Bazer, MPD Integrating the Healthcare Enterprise USA (IHE USA)
Level 1 Advance Directives Personal Advance Care Plan

Advance care plan is a general term for any documentation or other recordation of a person’s medical treatment goals, preferences, and priorities for some future point in time, under certain circumstances when the individual cannot make medical treatment decisions or communicate his or her goals, preferences, and priorities with the care team. An advance care plan places an emphasis on communication, as opposed to legal formalities. A PACP is a term specifically defined by HL7 as a template to facilitate the sharing of information expressed in advance care plans. A PACP may include the type of information contained in a living will and/or a durable medical power of attorney, and it also may include other medical interventions experience preference and instructions that help a healthcare agent make treatment decisions on the person’s behalf, and can be used by medical professionals to inform their medical interventions and treatment planning for the patient. Within the family of documents that have been defined under Consolidated CDA, the PACP document can be classified as a type of patient-generated document. The PACP document facilitates digital exchange of information previously and currently captured and shared using paper documents. Digital exchange of this type of data has become particularly critical within the context of COVID-19. To reduce the spread of disease, hospitals have disallowed patient family members and/or representatives to be present when the patient is admitted and as medical interventions are rendered, while also prohibiting acceptance of paper documents due to concerns of contagion. A PACP may include information relating to the appointment of a healthcare agent and alternate agents and establishing their authorized powers and limitations. It also may include information relating to any or all of the following: goals, preferences, and priorities for medical interventions (e.g., palliative and/or hospice care), including medical treatment preferences, based on the patient’s individual values, spiritual and religious beliefs, and personal definitions of quality of life; instructions to be followed after death (e.g., organ donation and autopsy); and information about who has signed, witnessed, and notarized the information authored by the individual, if available and appropriate. The set of recognized kinds of advance directive documents include concepts from the value set: Advance Directives Categories urn:oid:2.16.840.1.113883.11.20.9.69.4 which is openly available for reference in the National Library of Medicine’s Value Set Authority Center. It can be referenced using this url: https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.11.20.9.69.4/definition

HL7 CDA® R2 Implementation Guide: Personal Advance Care Plan (PACP) Document, Release 1 - US Realm STU Release 2 The PACP document is a CDA document template designed to share information created by an individual to express his or her care and medical treatment goals, preferences, and priorities for some future point in time, under certain circumstances when the individual cannot make medical treatment decisions or communicate his or her goals, preferences, and priorities with the care team. The purpose of the PACP document is to ensure that the information created by the individual is available and considered in clinical care planning, and the focus of the standard is sharing patient generated information. It should not matter if the source information is documented on a piece of paper, in a video recording, or in a consumer-controlled application that exists for this purpose. The standard provides a means to share this information in a standard way with a system that maintains a clinical record for the person. It is not intended to be a legal document or a digitization of a legal document. However, a PACP can reference a legal document, and it can represent information contained in a legal document such as the appointment of healthcare agents and the identity of witnesses or a notary.

Matt Elrod on behalf of ADVault, Inc. ADVault, Inc.
Level 1 Work Information Employment Status

This data element includes a coded concept, Employment Status, with time and date stamp and/or start date and end date. A person can be both employed and retired, and can have a different employment status for each job. Employment Status is a person's self-reported, coded relationship to working for pay, family earnings, or training (e.g. having one or more jobs, searching for work, etc.). A person’s Employment Status is independent of Job characteristics, e.g., not “full-time work” or “part-time work,” because many people have more than one job.

An information model of the Patient Work data elements, called Occupational Data for Health (ODH), has been published ( https://doi.org/10.1093/jamia/ocaa070) and the data are represented in the Federal Health Information Model (FHIM; https://fhim.org/). An HL7 informative EHR-S Functional Profile has been published (http://www.hl7.org/implement/standards/product_brief.cfm?product_id=498). A Guide to Collection of Occupational Data for Health (ODH) is in preparation. Logical Observation Identifiers Names and Codes (LOINC; https://loinc.org/) codes are available for each Patient Work Data Element, including Employment Status. The ODH code set (https://phinvads.cdc.gov/vads/ViewCodeSystem.action?id=2.16.840.1.114222.4.5.327) provides a value set for Employment Status as well as other Patient Work Data Elements (https://phinvads.cdc.gov/vads/SearchValueSets_search.action?searchOptions.searchText=ODH). The PHIN VADS ODH Hot Topics section provides downloadable files with Preferred Concept Names and Easy Read Descriptions for Employment Status values (https://phinvads.cdc.gov/vads/SearchVocab.action). Interoperability standard formats for all of the Patient Work Data Elements are published as aligned HL7 CDA, V2, and FHIR ODH templates as well as an IHE CDA profile ODH template. Related References: HL7 CDA® R2 Implementation Guide: Consolidated CDA Templates for Clinical Notes; Occupational Data for Health, Release 1 – US Realm; STU. http://www.hl7.org/implement/standards/product_brief.cfm?product_id=522 IHE Patient Care Coordination (PCC) Technical Framework Supplement: CDA Content Modules, Revision 2.6 – Trial Implementation. https://www.ihe.net/resources/technical_frameworks/#pcc HL7 FHIR Release 4.0.1 Profile: Occupational Data for Health (ODH), Release 1.0 STU. http://hl7.org/fhir/us/odh/STU1/ HL7 Version 2.9 Messaging Standard – An Application Protocol for Electronic Data Exchange in Healthcare Environments, Normative. http://www.hl7.org/implement/standards/product_brief.cfm?product_id=516 . Chapter 2C, Tables, Tables 0954-0959 provide the Patient Work Data Element component value sets. Chapter 3, Patient Administration, sections 3.4.15 and 3.4.18 describe the Patient Work Data Elements Employment Status and Combat Zone Period as Occupational Health (OH) segments; Retirement Date is included in the PD-1 segment.

Genevieve Luensman Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health
Level 1 Exposure/Contact Information Exposure/Contact Type The type of exposure/contact (environmental, activity, event, location, person, animal, etc.) to an agent.

HL7 FHIR® Implementation Guide: Electronic Case Reporting (eCR) based on FHIR R4 HL7 CDA® R2 Implementation Guide: Public Health Case Report - the Electronic Initial Case Report (eICR) HL7 FHIR: US Public Health Exposure Contact Information profile (Observation.component) HL7 CDA: Exposure/Contact Information Observation template (observation/participant)

Laura Conn
Level 1 Genomics Gene Studied

The human gene targeted for mutation/variant analysis.

SNOMED CT
https://www.snomed.org/snomed-ct/case-studies/binding-snomed-ct-and-gen…

LOINC
https://academic.oup.com/jamia/article/22/3/621/773317

HGNC Notation
https://www.genenames.org/

HGVS Nomenclature
https://varnomen.hgvs.org/

COSMIC
https://cancer.sanger.ac.uk/cosmic

ISCN
https://www.coriell.org/0/sections/support/global/iscn_help.aspx?PgId=2…

Steve Bratt CodeX (Common Oncology Data Elements eXtensions), a member-driven HL7 FHIR Accelerator
Level 1 Exposure/Contact Information Exposure/Contact Direction Whether the direction of exposure/contact is acquisition (patient is the target and another person, animal, location, etc. is the source) or transmission (patient is the source and another person, animal, location, etc. is the target).

HL7 FHIR® Implementation Guide: Electronic Case Reporting (eCR) based on FHIR R4 HL7 CDA® R2 Implementation Guide: Public Health Case Report - the Electronic Initial Case Report (eICR) HL7 FHIR: US Public Health Exposure Contact Information profile (Observation.component) HL7 CDA: Exposure/Contact Information Observation template (observation/participant)

Laura Conn
Level 1 Facility Information

Physical place of available services or resources.

Facility GPS Coordinates

Various: FHIR DSTU2, 3 and 4, CDA Release 2.0, HL7 V2 PL Data Type

Keith W. Boone Audacious Inquiry